Pharmerging Market Report

Global and Region Pharmerging Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：145
  • REPORT CODE：GMM927114
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Pharmerging market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Pharmergingmarket, defines the market attractiveness level of Pharmerging market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Pharmerging industry, describes the types of Pharmerging market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pharmerging market and the development prospects and opportunities of Pharmerging industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pharmerging market in Chapter 13.

    By Player:

    • Eisai

    • AstraZeneca

    • Bristol-Myers Squibb

    • Dainippon Sumitomo Pharma

    • Teva Pharmaceutical Industries

    • Pfizer

    • Daiichi Sankyo

    • F Hoffmann-La Roche

    • Kyowa Hakko Kirin

    • Novo Nordisk

    • CSL Behring

    • Biogen

    • Bayer

    • Boehringer Ingelheim

    • Amgen

    • Johnson & Johnson

    • Sanofi

    • Eli Lilly

    • Mitsubishi Tanabe Pharma

    • Sun Pharmaceutical

    • AbbVie

    • GlaxoSmithKline

    • Shire

    • Novartis

    By Type:

    • Tier 1

    • Tier 2

    • Tier 3

    By End-User:

    • Lung Cancer

    • Breast Cancer

    • Chronic Myeloid Leukemia

    • Lymphomas

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Pharmerging Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Pharmerging Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Pharmerging Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Pharmerging Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Pharmerging Market Analysis and Outlook to 2022

    • 7.1 Global Pharmerging Consumption (2017-2022)

    • 7.2 United States Pharmerging Consumption (2017-2022)

    • 7.3 Europe Pharmerging Consumption (2017-2022)

    • 7.4 China Pharmerging Consumption (2017-2022)

    • 7.5 Japan Pharmerging Consumption (2017-2022)

    • 7.6 India Pharmerging Consumption (2017-2022)

    • 7.7 South Korea Pharmerging Consumption (2017-2022)

    8 Region and Country-wise Pharmerging Market Analysis and Outlook to 2028

    • 8.1 Global Pharmerging Consumption Forecast (2022-2028)

    • 8.2 United States Pharmerging Consumption Forecast (2022-2028)

    • 8.3 Europe Pharmerging Consumption Forecast (2022-2028)

    • 8.4 China Pharmerging Consumption Forecast (2022-2028)

    • 8.5 Japan Pharmerging Consumption Forecast (2022-2028)

    • 8.6 India Pharmerging Consumption Forecast (2022-2028)

    • 8.7 South Korea Pharmerging Consumption Forecast (2022-2028)

    9 Global Pharmerging Market Outlook by Types and Applications to 2022

    • 9.1 Global Pharmerging Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tier 1 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tier 2 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Tier 3 Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pharmerging Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Chronic Myeloid Leukemia Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Lymphomas Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Pharmerging Market Outlook by Types and Applications to 2028

    • 10.1 Global Pharmerging Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Tier 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Tier 2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Tier 3 Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Pharmerging Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Chronic Myeloid Leukemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Lymphomas Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Pharmerging Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Pharmerging Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Pharmerging Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Pharmerging Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Pharmerging Market Competitive Analysis

    • 14.1 Eisai

      • 14.1.1 Eisai Company Details

      • 14.1.2 Eisai Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eisai Pharmerging Product and Service

    • 14.2 AstraZeneca

      • 14.2.1 AstraZeneca Company Details

      • 14.2.2 AstraZeneca Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AstraZeneca Pharmerging Product and Service

    • 14.3 Bristol-Myers Squibb

      • 14.3.1 Bristol-Myers Squibb Company Details

      • 14.3.2 Bristol-Myers Squibb Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bristol-Myers Squibb Pharmerging Product and Service

    • 14.4 Dainippon Sumitomo Pharma

      • 14.4.1 Dainippon Sumitomo Pharma Company Details

      • 14.4.2 Dainippon Sumitomo Pharma Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Dainippon Sumitomo Pharma Pharmerging Product and Service

    • 14.5 Teva Pharmaceutical Industries

      • 14.5.1 Teva Pharmaceutical Industries Company Details

      • 14.5.2 Teva Pharmaceutical Industries Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Teva Pharmaceutical Industries Pharmerging Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Pharmerging Product and Service

    • 14.7 Daiichi Sankyo

      • 14.7.1 Daiichi Sankyo Company Details

      • 14.7.2 Daiichi Sankyo Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Daiichi Sankyo Pharmerging Product and Service

    • 14.8 F Hoffmann-La Roche

      • 14.8.1 F Hoffmann-La Roche Company Details

      • 14.8.2 F Hoffmann-La Roche Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 F Hoffmann-La Roche Pharmerging Product and Service

    • 14.9 Kyowa Hakko Kirin

      • 14.9.1 Kyowa Hakko Kirin Company Details

      • 14.9.2 Kyowa Hakko Kirin Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Kyowa Hakko Kirin Pharmerging Product and Service

    • 14.10 Novo Nordisk

      • 14.10.1 Novo Nordisk Company Details

      • 14.10.2 Novo Nordisk Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novo Nordisk Pharmerging Product and Service

    • 14.11 CSL Behring

      • 14.11.1 CSL Behring Company Details

      • 14.11.2 CSL Behring Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 CSL Behring Pharmerging Product and Service

    • 14.12 Biogen

      • 14.12.1 Biogen Company Details

      • 14.12.2 Biogen Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Biogen Pharmerging Product and Service

    • 14.13 Bayer

      • 14.13.1 Bayer Company Details

      • 14.13.2 Bayer Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Bayer Pharmerging Product and Service

    • 14.14 Boehringer Ingelheim

      • 14.14.1 Boehringer Ingelheim Company Details

      • 14.14.2 Boehringer Ingelheim Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Boehringer Ingelheim Pharmerging Product and Service

    • 14.15 Amgen

      • 14.15.1 Amgen Company Details

      • 14.15.2 Amgen Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Amgen Pharmerging Product and Service

    • 14.16 Johnson & Johnson

      • 14.16.1 Johnson & Johnson Company Details

      • 14.16.2 Johnson & Johnson Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Johnson & Johnson Pharmerging Product and Service

    • 14.17 Sanofi

      • 14.17.1 Sanofi Company Details

      • 14.17.2 Sanofi Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Sanofi Pharmerging Product and Service

    • 14.18 Eli Lilly

      • 14.18.1 Eli Lilly Company Details

      • 14.18.2 Eli Lilly Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Eli Lilly Pharmerging Product and Service

    • 14.19 Mitsubishi Tanabe Pharma

      • 14.19.1 Mitsubishi Tanabe Pharma Company Details

      • 14.19.2 Mitsubishi Tanabe Pharma Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Mitsubishi Tanabe Pharma Pharmerging Product and Service

    • 14.20 Sun Pharmaceutical

      • 14.20.1 Sun Pharmaceutical Company Details

      • 14.20.2 Sun Pharmaceutical Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Sun Pharmaceutical Pharmerging Product and Service

    • 14.21 AbbVie

      • 14.21.1 AbbVie Company Details

      • 14.21.2 AbbVie Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 AbbVie Pharmerging Product and Service

    • 14.22 GlaxoSmithKline

      • 14.22.1 GlaxoSmithKline Company Details

      • 14.22.2 GlaxoSmithKline Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 GlaxoSmithKline Pharmerging Product and Service

    • 14.23 Shire

      • 14.23.1 Shire Company Details

      • 14.23.2 Shire Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Shire Pharmerging Product and Service

    • 14.24 Novartis

      • 14.24.1 Novartis Company Details

      • 14.24.2 Novartis Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Novartis Pharmerging Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Pharmerging

    • Figure Pharmerging Picture

    • Table Global Pharmerging Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pharmerging Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pharmerging Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Pharmerging Consumption by Country (2017-2022)

    • Figure United States Pharmerging Consumption and Growth Rate (2017-2022)

    • Table Europe Pharmerging Consumption and Growth Rate (2017-2022)

    • Figure China Pharmerging Consumption and Growth Rate (2017-2022)

    • Figure Japan Pharmerging Consumption and Growth Rate (2017-2022)

    • Figure India Pharmerging Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pharmerging Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmerging Consumption Forecast by Country (2022-2028)

    • Figure United States Pharmerging Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pharmerging Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Pharmerging Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pharmerging Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pharmerging Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pharmerging Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tier 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Tier 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Tier 3 Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Myeloid Leukemia Consumption and Growth Rate (2017-2022)

    • Figure Global Lymphomas Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Tier 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tier 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tier 3 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Myeloid Leukemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lymphomas Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Pharmerging Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Pharmerging Export by Region (Top 5 Countries) (2017-2028)

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Pharmerging Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Pharmerging Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Pharmerging Product and Service

    • Table Dainippon Sumitomo Pharma (Foundation Year, Company Profile and etc.)

    • Table Dainippon Sumitomo Pharma Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dainippon Sumitomo Pharma Pharmerging Product and Service

    • Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Pharmerging Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Pharmerging Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Pharmerging Product and Service

    • Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Pharmerging Product and Service

    • Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)

    • Table Kyowa Hakko Kirin Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Hakko Kirin Pharmerging Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Pharmerging Product and Service

    • Table CSL Behring (Foundation Year, Company Profile and etc.)

    • Table CSL Behring Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Behring Pharmerging Product and Service

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Pharmerging Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Pharmerging Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Pharmerging Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Pharmerging Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Pharmerging Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pharmerging Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Pharmerging Product and Service

    • Table Mitsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)

    • Table Mitsubishi Tanabe Pharma Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Pharmerging Product and Service

    • Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Pharmerging Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Pharmerging Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Pharmerging Product and Service

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Pharmerging Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Pharmerging Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Pharmerging Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US